# Hemodynamic Safety of Levobupivacaine vs Bupivacaine in Patients Over 65 Years Undergoing Hip Surgery

> **NCT03843970** · PHASE4 · UNKNOWN · sponsor: **Hospital Clínico Universitario de Valencia** · enrollment: 150 (estimated)

## Conditions studied

- Hip Fractures
- Hemodynamic Stability

## Interventions

- **DRUG:** Levobupivacaine Hydrochloride 0.5%
- **DRUG:** Isobaric bupivacaine 0.5%

## Key facts

- **NCT ID:** NCT03843970
- **Lead sponsor:** Hospital Clínico Universitario de Valencia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-14
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03843970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03843970, "Hemodynamic Safety of Levobupivacaine vs Bupivacaine in Patients Over 65 Years Undergoing Hip Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03843970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*